![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/05/15/2882426/0/en/PaxMedica-Files-Nasdaq-Delisting-Appeal-Notice-and-Prepares-for-Upcoming-FDA-Meeting-on-PAX-101.html
https://www.globenewswire.com/news-release/2024/05/07/2876748/0/en/PaxMedica-Provides-Company-Update-and-Continues-to-Advance-PAX-101-Regulatory-Strategy.html
https://www.globenewswire.com/news-release/2024/04/23/2867666/0/en/PaxMedica-Responds-to-Emergency-Request-for-IV-Suramin-and-Commits-to-Provide-Immediate-Access-to-PAX-101.html
https://www.globenewswire.com/news-release/2024/04/16/2864119/0/en/PaxMedica-Receives-Emergency-Request-for-IV-Suramin-from-African-Health-Ministry-for-Use-in-Treating-Fatal-Sleeping-Sickness.html
https://www.globenewswire.com/news-release/2024/04/11/2861889/0/en/PaxMedica-Achieves-Key-Milestone-in-the-Development-of-PAX-101-And-Provides-Update-on-Potential-NDA-Submission.html
https://www.globenewswire.com//news-release/2024/03/13/2845411/0/en/PaxMedica-Updated-Company-Presentation-Highlighting-Innovations-in-Autism-Spectrum-Disorder-Treatments.html
https://www.globenewswire.com//news-release/2023/11/17/2782538/0/en/PaxMedica-Inc-Featured-in-Syndicated-Broadcast-Highlighting-FDA-Type-B-Meeting-to-Review-PAX-101-Pivotal-Trial-Data.html